Stockscreener 앱 받기
134.09
0.16%
-0.21
전일 마감가:
$134.30
열려 있는:
$134.25
하루 거래량:
1.74M
Relative Volume:
0.72
시가총액:
$10.14B
수익:
-
순이익/손실:
$-274.62M
주가수익비율:
-30.98
EPS:
-4.3278
순현금흐름:
$-235.37M
1주 성능:
-0.14%
1개월 성능:
+1.02%
6개월 성능:
+104.69%
1년 성능:
+250.47%
1일 변동 폭
$134.05
$134.35
1주일 범위
$134.05
$134.46
52주 변동 폭
$34.34
$134.46
Apogee Therapeutics Inc Stock (APGE) Company Profile
명칭
Apogee Therapeutics Inc
전화
650-394-5230
주소
221 CRESCENT ST., WALTHAM
Compare APGE vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
134.09 | 10.16B | 0 | -274.62M | -235.37M | -4.3278 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-18 | 개시 | Truist | Hold |
| 2026-01-22 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-07 | 개시 | Wolfe Research | Peer Perform |
| 2025-12-17 | 개시 | Stephens | Overweight |
| 2025-12-10 | 개시 | Deutsche Bank | Buy |
| 2025-11-03 | 개시 | Craig Hallum | Buy |
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-09-25 | 개시 | RBC Capital Mkts | Outperform |
| 2025-07-07 | 재확인 | BTIG Research | Buy |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2024-11-25 | 개시 | Canaccord Genuity | Buy |
| 2024-05-10 | 개시 | BofA Securities | Buy |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-08-08 | 개시 | Guggenheim | Buy |
| 2023-08-08 | 개시 | Jefferies | Buy |
| 2023-08-08 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
| 2023-08-08 | 개시 | Wedbush | Outperform |
모두보기
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Is Apogee Therapeutics Inc. (APGE) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
APGE|Apogee Therapeutics Inc|Price:134.310|Chg%:+0.030 - TradingKey
Apogee Therapeutics Inc (APGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apogee Therapeutics Inc (APGE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apogee Therapeutics Inc (APGE) Institutional Confidence - TradingKey
TradingKey - TradingKey
Apogee Therapeutics Inc (APGE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apogee Therapeutics Inc (APGE) Income Statement - TradingKey
Apogee Therapeutics Inc (APGE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apogee Therapeutics Inc (APGE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
APGE|Apogee Therapeutics Inc|Price:134.310| - TradingKey
Why Wall Street Can't Get Enough of This Dividend King - The Motley Fool
Apogee Therapeutics Inc (APGE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Form 4 Apogee Therapeutics Inc For: 24 July By Investing.com - Investing.com South Africa
Apogee Therapeutics (APGE) CFO makes bona fide gift of 15,000 shares - Stock Titan
Understanding Momentum Shifts in (APGE) - Stock Traders Daily
Apogee Therapeutics stock hits all-time high at 134.34 USD By Investing.com - Investing.com South Africa
Apogee Therapeutics stock hits all-time high at 134.34 USD - Investing.com
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? - Yahoo Finance
Apogee Therapeutics (APGE) Proxy filing Summary - Quartr
Form 4 Apogee Therapeutics Inc For: 16 July By Investing.com - Investing.com South Africa
Apogee Therapeutics (APGE) CMO donates 8,000 shares to donor advised fund - Stock Titan
MSN Money - MSN
FMR LLC Significantly Reduces Stake in Apogee Therapeutics Inc. - GuruFocus
Apogee Therapeutics stock hits all-time high at 133.88 USD By Investing.com - Investing.com South Africa
AbbVie, Apogee Therapeutics filed HSR July 6, setting up Aug. 5 expiration - MLex
Apogee Therapeutics (NASDAQ: APGE) backs AbbVie’s $135.11‑per‑share all‑cash deal - Stock Titan
Apogee Therapeutics stock hits all-time high at 133.88 USD - Investing.com
What This Apogee Insider Move Might Mean After a 247% Stock Run - The Motley Fool
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock By Investing.com - Investing.com India
Form 4 Apogee Therapeutics Inc For: 10 July By Investing.com - Investing.com Australia
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock - Investing.com
Apogee Therapeutics (APGE) CEO logs stock sale and 75,046-share charitable gift - Stock Titan
Apogee Therapeutics (APGE) Jumps Into Focus, Is The Stock Fully Valued? - Yahoo Finance
Blackstone pledges $1.3 billion to help develop Apogee skin drug - MSN
AbbVie files $10.9bn Apogee deal in Germany - MLex
AbbVie to buy Apogee Therapeutics for $10.9 billion in cash - MSN
Wellington-affiliates report 564,326 APGE shares (APGE) ownership update - Stock Titan
T. Rowe Price boosts Apogee Therapeutics holding to 772,969 shares (NASDAQ: APGE) - Stock Titan
FMR LLC reports 2.49M Apogee Therapeutics shares (NASDAQ: APGE) - Stock Titan
Enterprise value to EBIT forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Price to earnings forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
My Takeaway On Apogee Therapeutics' Massive Cash Raise Humberto Cruz (GVA0ZiS739) - Mshale
Price to earnings forward of Apogee Therapeutics, Inc. – BOATS:APGE - TradingView
Apogee Therapeutics: My Take On Their Promising Eczema Drug Data Kb5089549 (eYX66guJPl) - Mshale
Enterprise value to EBITDA forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Price to book forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Apogee Therapeutics: AbbVie Acquisition And Merger Arbitrage Analysis APGE $APGE #APGE #stockmarket Diana Shnaider (BwfgwfruEs) - Mshale
Apogee Therapeutics | SCHEDULE 13G/A: Others - Moomoo
Apogee Therapeutics CMO Carl Dambkowski sells $730,070 in stock By Investing.com - Investing.com Australia
Apogee Therapeutics Inc (APGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Apogee Therapeutics Inc 주식 (APGE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer |
Jul 01 '26 |
Option Exercise |
22.86 |
4,125 |
94,298 |
183,373 |
| Dambkowski Carl | Chief Medical Officer |
Jul 01 '26 |
Sale |
132.74 |
5,500 |
730,070 |
177,873 |
2.44%
0.02%
자본화:
|
볼륨(24시간):